Q2 2023 13F Holders as of 6/30/2023
-
Type / Class
-
Equity / Common stock, par value $0.001 per share
-
Shares outstanding
-
148M
-
Number of holders
-
156
-
Total 13F shares, excl. options
-
77M
-
Shares change
-
+6.08M
-
Total reported value, excl. options
-
$1.46B
-
Value change
-
+$128M
-
Put/Call ratio
-
2.37
-
Number of buys
-
104
-
Number of sells
-
-68
-
Price
-
$18.95
Significant Holders of 89bio, Inc. - Common stock, par value $0.001 per share (ETNB) as of Q2 2023
221 filings reported holding ETNB - 89bio, Inc. - Common stock, par value $0.001 per share as of Q2 2023.
89bio, Inc. - Common stock, par value $0.001 per share (ETNB) has 156 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 77M shares
of 148M outstanding shares and own 51.96% of the company stock.
Largest 10 shareholders include RA CAPITAL MANAGEMENT, L.P. (11.4M shares), BlackRock Inc. (4.65M shares), STATE STREET CORP (4.64M shares), JANUS HENDERSON GROUP PLC (4.12M shares), PICTET ASSET MANAGEMENT SA (3.58M shares), VANGUARD GROUP INC (3.37M shares), Holocene Advisors, LP (2.64M shares), SUVRETTA CAPITAL MANAGEMENT, LLC (2.39M shares), FEDERATED HERMES, INC. (2.13M shares), and Boxer Capital, LLC (2.1M shares).
This table shows the top 156 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.